ArticleProceedings of the National Academy of Sciences of the United States of America2016

Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280.

Frank J A Dennissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.